Cesar Ugarte-Gil
Overview
Explore the profile of Cesar Ugarte-Gil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
1102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quansah N, Arriaga M, Calderon R, Shin S, Molldrem S, Niemann S, et al.
Lancet Microbe
. 2025 Mar;
:101106.
PMID: 40058374
No abstract available.
2.
Ohrnberg I, Karlsson L, Sayyab S, Paues J, Martinez-Enguita D, Gustafsson M, et al.
Sci Rep
. 2024 Nov;
14(1):29552.
PMID: 39609478
Tuberculosis (TB) poses a significant global health threat, with high mortality rates if left untreated. Current sputum-based TB treatment monitoring methods face numerous challenges, particularly in relation to sample collection...
3.
Nafade V, Sen P, Arentz M, Kadam R, Bigio J, Allen L, et al.
EClinicalMedicine
. 2024 Nov;
77:102899.
PMID: 39559185
No abstract available.
4.
Martinez-Perez G, Adetunji T, Salas Noriega F, Amoo O, Ugarte-Gil C, Ajeigbe A, et al.
BMC Prim Care
. 2024 Oct;
25(1):362.
PMID: 39394596
Background: Access to essential diagnostics is crucial for primary healthcare (PHC) in low-and-middle income countries (LMICs). Many LMICs have invested in equipping PHC with point-of-care (PoC) diagnostics for infectious diseases,...
5.
De la Cruz-Saldana T, Bustos J, Requena-Herrera M, Martinez-Merizalde N, Ortiz-Cam L, Caceres A, et al.
medRxiv
. 2024 Sep;
PMID: 39228722
Background: Cystic echinococcosis (CE) is a widespread neglected zoonotic disease caused by (EG) with a global burden of control in the billions of dollars. life cycle involves definitive, intermediate, and...
6.
Karlsson L, Ohrnberg I, Sayyab S, Martinez-Enguita D, Gustafsson M, Espinoza P, et al.
J Infect Dis
. 2024 Jul;
231(1):e47-e58.
PMID: 38962817
Background: Tuberculosis (TB) is among the largest infectious causes of death worldwide, and there is a need for a time- and resource-effective diagnostic methods. In this novel and exploratory study,...
7.
Faust L, Caceres-Cardenas G, Martinez L, Huddart S, Vidal J, Corilloclla-Torres R, et al.
Lancet Reg Health Am
. 2024 May;
33:100723.
PMID: 38800646
Background: The COVID-19 pandemic has significantly disrupted tuberculosis (TB) programs, making it urgent to focus TB elimination efforts on key populations. People experiencing incarceration are at high risk for TB,...
8.
Palomino-Padilla S, Caceres-Cardenas G, Calderon R, Ko A, Garnett L, Doan K, et al.
Front Public Health
. 2024 May;
12:1344295.
PMID: 38784579
Objectives: The COVID-19 pandemic caused a global shortage of nasopharyngeal (NP) swabs, required for RT-PCR testing. Canadian manufacturers were contacted to share NP swab innovations. The primary objective was to...
9.
Farhat M, Cox H, Ghanem M, Denkinger C, Rodrigues C, Abd El Aziz M, et al.
Nat Rev Microbiol
. 2024 Mar;
22(10):617-635.
PMID: 38519618
Drug-resistant tuberculosis (TB) is estimated to cause 13% of all antimicrobial resistance-attributable deaths worldwide and is driven by both ongoing resistance acquisition and person-to-person transmission. Poor outcomes are exacerbated by...
10.
Schiff H, Walker N, Ugarte-Gil C, Tebruegge M, Manousopoulou A, Garbis S, et al.
JCI Insight
. 2024 Mar;
9(8).
PMID: 38512356
BACKGROUNDNovel biomarkers to identify infectious patients transmitting Mycobacterium tuberculosis are urgently needed to control the global tuberculosis (TB) pandemic. We hypothesized that proteins released into the plasma in active pulmonary...